Helicobacter pylori infection and expressions of EGF, EGFR and c-erbB-2 proteins in gastric carcinoma

Folia Histochemica et Cytobiologica

Volumn 47, Issue 3, 2009, Pages 447-451

  Pryczynicz, Anna ^a   Guzińska Ustymowicz, Katarzyna ^a   Kemona, Andrzej ^a   Czyzewska, Jolanta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

c erbB 2; EGF; EGFR; Gastric carcinoma; Helicobacter pylori

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ARTICLE; CANCER PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; PROTEIN FAMILY; STOMACH CARCINOMA;

HELICOBACTER PYLORI;

EID: 77149144492     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0102-3     Document Type: Article

References (14)

1. Zatoński W, Tyczyński J. Nowotwory złooeliwe w Polsce w 1996 roku. Wyd. Centrum Onkologii - Instytut im. M Skłodowskiej- Curie, Warszawa 1999.
2. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First Amercian Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735-6740.
3. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127-31.
4. IARC. Schistosomes, liver flukes, and Helicobacter pylori, In: IARC Monograph on the evaluation of carcinogenic risks to humans, vol. 61. Lyon, France, 1994.
5. Nardone G. Risk factors for cancer development in Helicobacter pylori gastritis. Digest Liver Dis. 2000;32:190-192.
6. Fox JG. Review article: Helicobacter species and in vivo models of gastrointestinal cancer. Aliment Pharmacol The.r 1998;12:37-60.
7. Coyle WJ, Sedlack RE, Nemec R, et al. Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor. Am J Gastroenterol. 1999;94:2885-2889.
8. Takemura S, Yashiro M, Sunami T, Tendo M, Hirakawa K. Novel models for human scirrhous gastric carcinoma in vivo. Cancer Sci. 2004;95:893-900
9. Yokota J, Yamamoto T, Miyajima N, Toyoshima K, Nomura N, Sakamoto H, Yoshida T, Terada M, Sagimura T. Genetic alternations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene. 1988;2:283-287
10. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. The American Journal of Surgical Pathology. 1996; 20:1161-1181.
11. Wong BC, Wang WP, So WH, et al. Epidermal growth factor and its receptor in chronic active gastritis and gastroduodenal ulcer before and after Helicobacter pylori eradication. Aliment Pharmacol Ther. 2000;15:1459- 1465.
12. Wallasch C, Crabtree JE, Bevec D, et al. Helicobacter pylori-stimulated EGF receptor transactivation requires metalloprotease cleveage of HB-EGF. Biochem Biophys Res Commun. 2002;295:695-701.
13. Wang YL, Sheu BS, Yang HB, et al. Overexpression of c-erb-B2 proteins in tumor and non-tumor parts of gastric adenocarcinoma-emphasis on its relation to H. pylori infection and clinicohistological characteristics. Hepatogastroenterology. 2002;49: 1172-1176.
14. Wang J, Chi DS, Kalin GB, et al. Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions. Dig Dis Sci. 2002;47:107-113.